NCT02313064 - Oral CXA-10 Study in Healthy Volunteers | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

January 31, 2015

Primary Completion Date

May 31, 2015

Study Completion Date

June 30, 2015

Conditions

Chronic Kidney Injury

Interventions

DRUG

CXA-10

Part A has sequential single ascending doses will be administered in up to 5 cohorts of subjects. Each cohort of subjects will be randomized to receive a single dose of CXA-10 or placebo in, a fasted state. Part B has 2 periods and subjects will receive two doses of the selected dose of CXA-10.

DRUG

CXA-10 placebo

Trial Locations (1)

49007

Jasper Clinical Research & Development, Inc., Kalamazoo